{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:20:08Z","timestamp":1781871608204,"version":"3.54.5"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common as the global economy grows and living standards improve. Timely and effective preventions and treatments for NAFLD are urgently needed. Retinol-binding protein-4 (RBP4), the protein that transports retinol through the circulation, was found to be positively related to diabetes, obesity, cardiovascular disease, and other metabolic diseases. Observational studies on the association between serum RBP4 level and the prevalence of NAFLD found contradictory results. Some of the underlying mechanisms responsible for this association have been revealed, and the possible clinical implications of treating NAFLD by targeting RBP4 have been demonstrated. Future studies should focus on the predictive value of RBP4 on NAFLD development and its potential as a therapeutic target in NAFLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002135","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T09:00:34Z","timestamp":1657011634000},"page":"1182-1189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Retinol-binding protein-4 and nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"135","author":[{"given":"Hangkai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2018","journal-title":"J Hepatol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20250603","first-page":"S1542","article-title":"A meta-analysis on the global prevalence,risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","author":"Toh","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(Suppl 1)","key":"R4-20250603","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000333210","article-title":"Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area","volume":"84","author":"Cho","year":"2011","journal-title":"Digestion"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1093\/nar\/11.22.7769","article-title":"Cloning and sequencing of a full length cDNA coding for human retinol-binding protein","volume":"11","author":"Colantuoni","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1194\/jlr.R037648","article-title":"Retinol and retinyl esters: biochemistry and physiology","volume":"54","author":"O\u2019Byrne","year":"2013","journal-title":"J Lipid Res"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI105889","article-title":"Retinol-binding protein: the transport protein for vitamin A in human plasma","volume":"47","author":"Kanai","year":"1968","journal-title":"J Clin Invest"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0021-9258(18)46017-6","article-title":"Retinoids and retinoid-binding protein expression in rat adipocytes","volume":"267","author":"Tsutsumi","year":"1992","journal-title":"J Biol Chem"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1016\/S0021-9258(19)49651-8","article-title":"Differentiation-dependent expression of retinoid-binding proteins in BFC-1 beta adipocytes","volume":"267","author":"Zovich","year":"1992","journal-title":"J Biol Chem"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-nutr-080508-141027","article-title":"Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism","volume":"30","author":"von Lintig","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1074\/jbc.R111.303990","article-title":"Metabolism of carotenoids and retinoids related to vision","volume":"287","author":"von Lintig","year":"2011","journal-title":"J Biol Chem"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2008.09.002","article-title":"Retinoic acid synthesis and signaling during early organogenesis","volume":"134","author":"Duester","year":"2008","journal-title":"Cell"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/dev.065938","article-title":"Retinoic acid signalling during development","volume":"139","author":"Rhinn","year":"2012","journal-title":"Development"},{"key":"R16-20250603","first-page":"229","article-title":"STRA6: role in cellular retinol uptake and efflux","volume":"4","author":"Kelly","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1073\/pnas.1011115108","article-title":"Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses","volume":"108","author":"Berry","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/MCB.00505-12","article-title":"Cross talk between signaling and vitamin A transport by the retinol-binding protein receptor STRA6","volume":"32","author":"Berry","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R19-20250603","first-page":"4197","article-title":"Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid","volume":"61","author":"Szeto","year":"2001","journal-title":"Cancer Res"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1086\/512203","article-title":"Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation","volume":"80","author":"Pasutto","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"24528","DOI":"10.1074\/jbc.M113.484014","article-title":"The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye","volume":"288","author":"Berry","year":"2013","journal-title":"J Biol Chem"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbapap.2004.09.023","article-title":"Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis","volume":"1703","author":"Raghu","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbrc.2005.08.227","article-title":"Biochemical basis for retinol deficiency induced by the I41N and G75D mutations in human plasma retinol-binding protein","volume":"336","author":"Folli","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/MCB.00775-12","article-title":"Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6","volume":"32","author":"Berry","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"11118","DOI":"10.1021\/bi00160a023","article-title":"Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin","volume":"31","author":"Noy","year":"1992","journal-title":"Biochemistry"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2007-0209","article-title":"Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes","volume":"92","author":"Jia","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kl\u00f6ting","year":"2007","journal-title":"Cell Metab"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/oby.2007.264","article-title":"Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women","volume":"15","author":"Lee","year":"2007","journal-title":"Obesity"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0028-1100411","article-title":"Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome","volume":"41","author":"Makino","year":"2008","journal-title":"Horm Metab Res"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4093\/dmj.2012.36.6.415","article-title":"Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes","volume":"36","author":"Kim","year":"2012","journal-title":"Diabetes Metab J"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/MCB.01106-13","article-title":"Downregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocyte-specific STRA6 knockdown in vivo","volume":"34","author":"Zemany","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/MCB.06193-11","article-title":"Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism","volume":"32","author":"Norseen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"31309","DOI":"10.1073\/pnas.2013877117","article-title":"Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4","volume":"117","author":"Moraes-Vieira","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diabres.2007.08.016","article-title":"Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"79","author":"Wu","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","article-title":"Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease","volume":"68","author":"Seo","year":"2008","journal-title":"Clin Endocrinol"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diabet.2019.04.009","article-title":"Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease","volume":"46","author":"Wang","year":"2019","journal-title":"Diabetes Metab"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/MCG.0b013e3181a0998d","article-title":"Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease","volume":"43","author":"Alkhouri","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1872-034X.2009.00534.x","article-title":"Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease","volume":"39","author":"Schina","year":"2009","journal-title":"Hepatol Res"},{"key":"R40-20250603","first-page":"705","article-title":"Vaspin, resistin, retinol-binding protein-4, interleukin-1( and interleukin-6 in patients with nonalcoholic fatty liver disease","volume":"15","author":"Polyzos","year":"2016","journal-title":"Ann Hepatol"},{"key":"R41-20250603","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2217\/bmm.13.13","article-title":"Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease","volume":"7","author":"Boyraz","year":"2013","journal-title":"Biomark Med"},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MPG.0b013e3182722aee","article-title":"Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level","volume":"56","author":"Huang","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2008.12.031","article-title":"Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease","volume":"7","author":"Nobili","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.26227","article-title":"Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b2-dependent pathway","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"key":"R45-20250603","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/hep.28659","article-title":"Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice","volume":"64","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1210\/jc.2016-1320","article-title":"Retinol-binding protein 4 induces hepatic mitochondrial dysfunction and promotes hepatic steatosis","volume":"101","author":"Liu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-20250603","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1021\/acs.jmedchem.9b00352","article-title":"Design, synthesis, and preclinical efficacy of novel nonretinoid antagonists of retinol-binding protein 4 in the mouse model of hepatic steatosis","volume":"62","author":"Cioffi","year":"2019","journal-title":"J Med Chem"},{"key":"R48-20250603","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1248\/bpb.35.369","article-title":"Fenretinide ameliorates insulin resistance and fatty liver in obese mice","volume":"35","author":"Koh","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"R49-20250603","doi-asserted-by":"crossref","first-page":"E1420","DOI":"10.1152\/ajpendo.00362.2009","article-title":"Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis","volume":"297","author":"Preitner","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R50-20250603","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1158\/0008-5472.CAN-08-0553","article-title":"Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer","volume":"68","author":"Johansson","year":"2008","journal-title":"Cancer Res"},{"key":"R51-20250603","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbalip.2011.09.011","article-title":"Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice","volume":"1811","author":"Tan","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R52-20250603","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"R53-20250603","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/biof.1209","article-title":"Retinol binding protein-4 predicts incident diabetes in Asian Indian men with prediabetes","volume":"41","author":"Ram","year":"2015","journal-title":"Biofactors"},{"key":"R54-20250603","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.metabol.2009.06.013","article-title":"Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus","volume":"58","author":"Chen","year":"2009","journal-title":"Metabolism"},{"key":"R55-20250603","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1758-5996-6-72","article-title":"Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients","volume":"6","author":"Deng","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"R56-20250603","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2008.10.004","article-title":"Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects","volume":"400","author":"Lee","year":"2008","journal-title":"Clin Chim Acta"},{"key":"R57-20250603","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1507\/endocrj.K09E-096","article-title":"Serum retinol-binding protein 4 is elevated and positively associated with insulin resistance in postmenopausal women","volume":"56","author":"An","year":"2009","journal-title":"Endocr J"},{"key":"R58-20250603","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tibs.2015.12.006","article-title":"Mechanisms and dynamics of protein acetylation in mitochondria","volume":"41","author":"Baeza","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"R59-20250603","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"key":"R60-20250603","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2015.03.036","article-title":"Retinol binding protein 4 induces mitochondrial dysfunction and vascular oxidative damage","volume":"240","author":"Wang","year":"2015","journal-title":"Atherosclerosis"},{"key":"R61-20250603","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-006-0006-3","article-title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome","volume":"30","author":"Weiping","year":"2006","journal-title":"Endocrine"},{"key":"R62-20250603","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1210\/jc.2008-0077","article-title":"Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance","volume":"93","author":"Kowalska","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-20250603","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/jc.2006-1815","article-title":"Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes","volume":"92","author":"Gavi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-20250603","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/BF03345631","article-title":"Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome","volume":"31","author":"Diamanti-Kandarakis","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"R65-20250603","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc07-2265","article-title":"Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Hutchison","year":"2008","journal-title":"Diabetes Care"},{"key":"R66-20250603","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1155\/2009\/725948","article-title":"Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease","volume":"26","author":"Al-Daghri","year":"2009","journal-title":"Dis Markers"},{"key":"R67-20250603","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"R68-20250603","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/MCB.00820-12","article-title":"Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism","volume":"32","author":"Farjo","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R69-20250603","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.1136244","article-title":"A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A","volume":"315","author":"Kawaguchi","year":"2007","journal-title":"Science"},{"key":"R70-20250603","doi-asserted-by":"crossref","first-page":"15269","DOI":"10.1074\/jbc.RA118.004294","article-title":"Liver-secreted RBP4 does not impair glucose homeostasis in mice","volume":"293","author":"Fedders","year":"2018","journal-title":"J Biol Chem"},{"key":"R71-20250603","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jcmgh.2020.07.006","article-title":"Impaired hepatic vitamin A metabolism in NAFLD mice leading to vitamin A accumulation in hepatocytes","volume":"11","author":"Saeed","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R72-20250603","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.ki.5002372","article-title":"Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients","volume":"72","author":"Raila","year":"2007","journal-title":"Kidney Int"},{"key":"R73-20250603","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13813451003631421","article-title":"Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients","volume":"116","author":"Ulgen","year":"2010","journal-title":"Arch Physiol Biochem"},{"key":"R74-20250603","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.5114\/aoms.2018.79565","article-title":"Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus","volume":"15","author":"Wang","year":"2018","journal-title":"Arch Med Sci"},{"key":"R75-20250603","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1159\/000346205","article-title":"Effects of exercise training on circulating retinol-binding protein 4 and cardiovascular disease risk factors in obese men","volume":"5","author":"Numao","year":"2012","journal-title":"Obes Facts"},{"key":"R76-20250603","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s11695-010-0200-5","article-title":"Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women","volume":"20","author":"Broch","year":"2010","journal-title":"Obes Surg"},{"key":"R77-20250603","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2006-1839","article-title":"Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects","volume":"92","author":"Haider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R78-20250603","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2265.2007.03156.x","article-title":"Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass","volume":"69","author":"G\u00f3mez-Ambrosi","year":"2007","journal-title":"Clin Endocrinol"},{"key":"R79-20250603","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/oby.2008.391","article-title":"Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss","volume":"16","author":"Tschoner","year":"2008","journal-title":"Obesity"},{"key":"R80-20250603","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.2007-2028","article-title":"Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women","volume":"93","author":"Lim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R81-20250603","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clinbiochem.2018.04.017","article-title":"Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease","volume":"56","author":"Cai","year":"2018","journal-title":"Clin Biochem"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:07:22Z","timestamp":1748977642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002135","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}